Metastatic melanoma Trials in Tampa, United States
Conditions / Metastatic melanoma / Tampa, United States
Metastatic melanoma has been the subject of sustained clinical investigation across multiple research sites.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01415167 | PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy | COMPLETED | — |
| NCT00986661 | A Study to Assess PV-10 Chemoablation of Cancer of the Liver | UNKNOWN | PHASE1 |
| NCT00730639 | A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies | COMPLETED | PHASE1 |
| NCT06500455 | Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain | RECRUITING | PHASE3 |
| NCT03645928 | Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors | RECRUITING | PHASE2 |
| NCT02298959 | Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT03415126 | A Study of ASN007 in Patients With Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT04511013 | A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases | RECRUITING | PHASE2 |
| NCT01989585 | Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT02360579 | Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma | COMPLETED | PHASE2 |